Presentation is loading. Please wait.

Presentation is loading. Please wait.

Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo.

Similar presentations


Presentation on theme: "Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo."— Presentation transcript:

1 Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo Normotensive patients 4.28 3.84 Hypertensive patients 4.90 5.61 Lubsen J et al. J Hypertens 2005, 23:

2 Angiography/CABG in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Angiography Nifedipine Placebo Normotensive patients 5.44 6.86 Hypertensive patients 5.50 6.53 CABG 1.48 2.19 1.75 1.94 Lubsen J et al. J Hypertens 2005, 23:

3 Stroke in normotensive and hypertensive patients at baseline (events per 100 patient- years of follow-up) Any stroke or TIA Nifedipine Placebo Normotensive patients 0.71 0.97 Hypertensive patients 1.31 1.81 Debilitating stroke 0.30 0.26 0.52 0.77 Lubsen J et al. J Hypertens 2005, 23:

4 New overt heart failure in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) New overt heart failure Nifedipine Placebo Normotensive patients 0.43 0.50 Hypertensive patients 0.49 0.78 Lubsen J et al. J Hypertens 2005, 23:


Download ppt "Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo."

Similar presentations


Ads by Google